164 related articles for article (PubMed ID: 8631850)
1. RANTES and MCP-3 antagonists bind multiple chemokine receptors.
Gong JH; Uguccioni M; Dewald B; Baggiolini M; Clark-Lewis I
J Biol Chem; 1996 May; 271(18):10521-7. PubMed ID: 8631850
[TBL] [Abstract][Full Text] [Related]
2. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes.
Uguccioni M; D'Apuzzo M; Loetscher M; Dewald B; Baggiolini M
Eur J Immunol; 1995 Jan; 25(1):64-8. PubMed ID: 7531149
[TBL] [Abstract][Full Text] [Related]
3. Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B.
Combadiere C; Ahuja SK; Van Damme J; Tiffany HL; Gao JL; Murphy PM
J Biol Chem; 1995 Dec; 270(50):29671-5. PubMed ID: 8530354
[TBL] [Abstract][Full Text] [Related]
4. Binding of RANTES, MCP-1, MCP-3, and MIP-1alpha to cells in human skin.
Hub E; Rot A
Am J Pathol; 1998 Mar; 152(3):749-57. PubMed ID: 9502417
[TBL] [Abstract][Full Text] [Related]
5. Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors.
Gong X; Gong W; Kuhns DB; Ben-Baruch A; Howard OM; Wang JM
J Biol Chem; 1997 May; 272(18):11682-5. PubMed ID: 9115216
[TBL] [Abstract][Full Text] [Related]
6. Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle.
Mirzadegan T; Diehl F; Ebi B; Bhakta S; Polsky I; McCarley D; Mulkins M; Weatherhead GS; Lapierre JM; Dankwardt J; Morgans D; Wilhelm R; Jarnagin K
J Biol Chem; 2000 Aug; 275(33):25562-71. PubMed ID: 10770925
[TBL] [Abstract][Full Text] [Related]
7. Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3.
Bonini JA; Martin SK; Dralyuk F; Roe MW; Philipson LH; Steiner DF
DNA Cell Biol; 1997 Oct; 16(10):1249-56. PubMed ID: 9364936
[TBL] [Abstract][Full Text] [Related]
8. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine.
Dahinden CA; Geiser T; Brunner T; von Tscharner V; Caput D; Ferrara P; Minty A; Baggiolini M
J Exp Med; 1994 Feb; 179(2):751-6. PubMed ID: 7507512
[TBL] [Abstract][Full Text] [Related]
9. The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation.
Monteclaro FS; Charo IF
J Biol Chem; 1996 Aug; 271(32):19084-92. PubMed ID: 8702581
[TBL] [Abstract][Full Text] [Related]
10. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody.
Heath H; Qin S; Rao P; Wu L; LaRosa G; Kassam N; Ponath PD; Mackay CR
J Clin Invest; 1997 Jan; 99(2):178-84. PubMed ID: 9005985
[TBL] [Abstract][Full Text] [Related]
11. Human RANTES acts as a receptor antagonist for guinea pig eotaxin in vitro and in vivo.
Marleau S; Griffiths-Johnson DA; Collins PD; Bakhle YS; Williams TJ; Jose PJ
J Immunol; 1996 Nov; 157(9):4141-6. PubMed ID: 8892650
[TBL] [Abstract][Full Text] [Related]
12. Chemokines in the limbal form of vernal keratoconjunctivitis.
Abu El-Asrar AM; Struyf S; Al-Kharashi SA; Missotten L; Van Damme J; Geboes K
Br J Ophthalmol; 2000 Dec; 84(12):1360-6. PubMed ID: 11090473
[TBL] [Abstract][Full Text] [Related]
13. Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors: binding and signaling of MCP3 through shared as well as unique receptors on monocytes and neutrophils.
Xu LL; McVicar DW; Ben-Baruch A; Kuhns DB; Johnston J; Oppenheim JJ; Wang JM
Eur J Immunol; 1995 Sep; 25(9):2612-7. PubMed ID: 7589134
[TBL] [Abstract][Full Text] [Related]
14. Monocyte chemoattractant protein-2 can exert its effects through the MCP-1 receptor (CC CKR2B).
Yamagami S; Tanaka H; Endo N
FEBS Lett; 1997 Jan; 400(3):329-32. PubMed ID: 9009224
[TBL] [Abstract][Full Text] [Related]
15. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.
Uguccioni M; Mackay CR; Ochensberger B; Loetscher P; Rhis S; LaRosa GJ; Rao P; Ponath PD; Baggiolini M; Dahinden CA
J Clin Invest; 1997 Sep; 100(5):1137-43. PubMed ID: 9276730
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils.
Ponath PD; Qin S; Post TW; Wang J; Wu L; Gerard NP; Newman W; Gerard C; Mackay CR
J Exp Med; 1996 Jun; 183(6):2437-48. PubMed ID: 8676064
[TBL] [Abstract][Full Text] [Related]
17. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
18. Cloning, expression, and characterization of the human eosinophil eotaxin receptor.
Daugherty BL; Siciliano SJ; DeMartino JA; Malkowitz L; Sirotina A; Springer MS
J Exp Med; 1996 May; 183(5):2349-54. PubMed ID: 8642344
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo.
McQuibban GA; Gong JH; Wong JP; Wallace JL; Clark-Lewis I; Overall CM
Blood; 2002 Aug; 100(4):1160-7. PubMed ID: 12149192
[TBL] [Abstract][Full Text] [Related]
20. Gene transfer of RANTES and MCP-1 chemokine antagonists prolongs cardiac allograft survival.
Fleury S; Li J; Simeoni E; Fiorini E; von Segesser LK; Kappenberger L; Vassalli G
Gene Ther; 2006 Jul; 13(14):1104-9. PubMed ID: 16541117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
